{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T07:28:55Z","timestamp":1793518135665,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,10,1]],"date-time":"2012-10-01T00:00:00Z","timestamp":1349049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1016\/j.drugalcdep.2012.02.021","type":"journal-article","created":{"date-parts":[[2012,3,20]],"date-time":"2012-03-20T17:16:16Z","timestamp":1332263776000},"page":"260-266","source":"Crossref","is-referenced-by-count":48,"title":["Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics"],"prefix":"10.1016","volume":"125","author":[{"given":"Bach Xuan","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arto","family":"Ohinmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anh Thuy","family":"Duong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phu Xuan","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Mills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Houston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0005","doi-asserted-by":"crossref","first-page":"e1000423","DOI":"10.1371\/journal.pmed.1000423","article-title":"Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine","volume":"8","author":"Alistar","year":"2011","journal-title":"PLoS Med."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0010","series-title":"Decision Modelling for Health Economic Evaluation","author":"Andrew Briggs","year":"2006"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1089\/apc.2009.0242","article-title":"Integrated opioid use disorder and HIV treatment: rationale, clinical guidelines for addiction treatment, and review of interactions of antiretroviral agents and opioid agonist therapies","volume":"24","author":"Batkis","year":"2010","journal-title":"AIDS Patient Care STDS"},{"issue":"Suppl. 3","key":"10.1016\/j.drugalcdep.2012.02.021_bib0020","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1097\/01.aids.0000390086.14941.91","article-title":"Injection drug use, HIV and the current response in selected low-income and middle-income countries","volume":"24","author":"Bergenstrom","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0025","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drugpo.2009.10.004","article-title":"Methadone as HIV prevention: high volume methadone sites to decrease HIV incidence rates in resource limited settings","volume":"21","author":"Bruce","year":"2009","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0272989X8500500205","article-title":"Probabilistic sensitivity analysis using Monte Carlo simulation. A practical approach","volume":"5","author":"Doubilet","year":"1985","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0035","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1097\/QAD.0b013e328331910c","article-title":"AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatment","volume":"23","author":"Falster","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0040","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2007.05.003","article-title":"Predictors of methadone maintenance treatment utilization in a multisite cohort of illicit opioid users (OPICAN)","volume":"34","author":"Fischer","year":"2008","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0045","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/QAD.0b013e328335cd8a","article-title":"Antiretroviral medication adherence and class-specific resistance in a large prospective clinical trial","volume":"24","author":"Gardner","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0050","unstructured":"General Statistics Office, 2010. GDP per capital, 2009. www.gsogovvn.com (accessed 26.06.11)."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0055","unstructured":"Health Policy Initiative, 2008. Costs Associated with Implementing an Opioid Substitution Therapy Program for IDUs in Viet Nam. http:\/\/wwwhealthpolicyinitiativecom\/Publications\/Documents\/1078_1_Costs_Associated_with_OST_FINAL_accpdf."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0060","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/09540120412331319714","article-title":"An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART","volume":"17","author":"Jelsma","year":"2005","journal-title":"AIDS Care"},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2012.02.021_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/135965350801302S07","article-title":"World Health Organization surveys to monitor HIV drug resistance prevention and associated factors in sentinel antiretroviral treatment sites","volume":"13","author":"Jordan","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0070","unstructured":"Josefine Nilsson, Dina Vemming Oksen, 2010. Antiretroviral therapy adherence in Quang Ninh, Vietnam \u2013 Analyzing results on adherence from a randomized controlled trial. Bachelor Thesis Goteborgs University Full text: http:\/\/gupeaubguse\/bitstream\/2077\/23157\/1\/gupea_2077_23157_1pdf."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0075","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1524-4733.2005.08103.x","article-title":"Thresholds in cost-effectiveness analysis\u2014more of the story","volume":"8","author":"Laufer","year":"2005","journal-title":"Value Health"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0080","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1089\/apc.2006.0192","article-title":"Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy","volume":"21","author":"Lucas","year":"2007","journal-title":"AIDS Patient Care STDS"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0085","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/503905","article-title":"Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups","volume":"42","author":"Lucas","year":"2006","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 5","key":"10.1016\/j.drugalcdep.2012.02.021_bib0090","doi-asserted-by":"crossref","first-page":"S409","DOI":"10.1086\/421405","article-title":"Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study","volume":"38","author":"Lucas","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"Suppl. 2","key":"10.1016\/j.drugalcdep.2012.02.021_bib0095","doi-asserted-by":"crossref","first-page":"ii28","DOI":"10.1136\/sti.2010.044255","article-title":"Derivation of parameters used in spectrum for eligibility for antiretroviral therapy and survival on antiretroviral therapy","volume":"86","author":"Mahy","year":"2010","journal-title":"Sex. Transm. Infect."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0100","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S0140-6736(10)60232-2","article-title":"HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage","volume":"375","author":"Mathers","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0105","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/1545109710387301","article-title":"Virologic and Immunologic Outcomes of the second-line regimens of antiretroviral therapy among HIV-infected patients in Thailand","volume":"10","author":"May Myat","year":"2011","journal-title":"J. Int. Assoc. Physicians AIDS Care (Chic.)"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/QAD.0b013e32834564e9","article-title":"Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda","volume":"25","author":"Mills","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0115","series-title":"National HIV AIDS Care and Treatment Guidelines","author":"Ministry of Health","year":"2007"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0120","series-title":"National Strategy on HIV\/AIDS Prevention and Control Towards 2010","author":"Ministry of Health","year":"2008"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0125","series-title":"The Annual Review of HIV\/AIDS Control and Prevention in 2008 and Action Plan in 2009","author":"Ministry of Health","year":"2009"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0130","series-title":"National Guidelines on HIV\/AIDS Diagnosis, Care and Treatment","author":"Ministry of Health","year":"2009"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0135","series-title":"2009 Antiretroviral Therapy Cohort Assessment and HIV Drug Resistance Early Warning Indicators","author":"Ministry of Health","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0140","series-title":"Effectiveness Evaluation of the Pilot Program for Treatment of Opioid Dependence with Methadone in Hai Phong and Ho Chi Minh Cities","author":"Ministry of Health","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0145","series-title":"Report on Current Situation of the HIV Epidemics in Vietnam, from January 1, 2009 to December 12, 2009","author":"Ministry of Health","year":"2010"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0150","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1099-1050(200004)9:3<235::AID-HEC502>3.0.CO;2-O","article-title":"Development of WHO guidelines on generalized cost-effectiveness analysis","volume":"9","author":"Murray","year":"2000","journal-title":"Health Econ."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsat.2010.03.008","article-title":"Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996\u20132006","volume":"39","author":"Nosyk","year":"2010","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0160","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00019053-200624040-00006","article-title":"Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment","volume":"24","author":"Philips","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0165","doi-asserted-by":"crossref","DOI":"10.3310\/hta8360","article-title":"Review of guidelines for good practice in decision-analytic modelling in health technology assessment","volume":"8","author":"Philips","year":"2004","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0170","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QAD.0b013e3283324283","article-title":"The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals","volume":"24","author":"Ray","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0175","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1086\/630209","article-title":"Retention in opioid substitution treatment: a major predictor of long-term virological success for HIV-infected injection drug users receiving antiretroviral treatment","volume":"49","author":"Roux","year":"2009","journal-title":"Clin. Infect. Dis"},{"issue":"11","key":"10.1016\/j.drugalcdep.2012.02.021_bib0235","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1111\/j.1360-0443.2008.02323.x","article-title":"MANIF2000 cohort study group. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study","volume":"103","author":"Roux","year":"2008","journal-title":"Addiction."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0180","unstructured":"The Commission on Aids in Asia, 2008. Redefining AIDS in Asia: Crafting an effective response. Oxford University Press, Oxford, Available at http:\/\/wwwunaidsorg\/en\/media\/unaids\/contentassets\/dataimport\/pub\/report\/2008\/20080326_report_commission_aids_enpdf."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0185","article-title":"Changes in drug use are associated with health-related quality of life improvements among methadone maintenance patients with HIV\/AIDS","author":"Tran","year":"2011","journal-title":"Qual Life Res."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0190","article-title":"Cost-effectiveness of methadone maintenance treatment for HIV-positive drug users in Vietnam","author":"Tran","year":"2011","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0240","doi-asserted-by":"crossref","DOI":"10.1080\/09540121.2011.555749","article-title":"Determinants of health-related quality of life in adults living with HIV in Vietnam","author":"Tran","year":"2011","journal-title":"AIDS Care"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0195","unstructured":"TreeAge Software Inc., 2011. TreeAge Pro Version: 2011 Build-Id: 1.0.12.1-v20110119, Williamstown, MA."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0200","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2165\/00019053-200017050-00003","article-title":"Decision analytic modelling in the economic evaluation of health technologies. A consensus statement. Consensus Conference on Guidelines on Economic Modelling in Health Technology Assessment","volume":"17","author":"University of Sheffield","year":"2000","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0205","unstructured":"Vietnam Administration of HIV\/AIDS Control, 2010. Report on the current situation of HIV infection in 2009. Hanoi: Vietnam http:\/\/www.vaac.gov.vn\/Desktop.aspx\/Noi-dung\/Tinh-hinh-dich\/Tinh_hinh_dich_nhiem_HIVAIDS_toan_quoc_nam_2009\/."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0210","unstructured":"Vietnam Ministry of Health, 2010. Cost of providing HIV care and treatment services in Vietnam. Hanoi."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0215","unstructured":"Vu Van Tam, Do Duy Cuong, Cao Hong Tu, 2010. DOTARV: A randomised controlled trial to assess antiretroviral treatment strategies in relation to adherence, resistance and virological treatment failure. UNAIDS Seminar 06\/04\/2010 Available at http:\/\/wwwunaidsorgvn\/sitee\/images\/stories\/dotarv_presentation_hsph_6_april_2010_engpdf Hanoi, Vietnam."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0220","unstructured":"WHO, UNAIDS, UNICEF, 2010. Towards Universal Access: Setting Priority HIV\/AIDS Interventions in the Health Sector. Progress Report 2010. Geneva."},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0225","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0140-6736(10)60832-X","article-title":"Treatment and care for injecting drug users with HIV infection: a review of barriers and ways forward","volume":"376","author":"Wolfe","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.drugalcdep.2012.02.021_bib0230","series-title":"Antiretroviral Therapy for HIV Infection in Adults and Adolescents: Recommendations for a Public Health Approach\u20132006 rev","author":"World Health Organization","year":"2006"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871612000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,21]],"date-time":"2024-04-21T19:58:41Z","timestamp":1713729521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871612000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,10]]}},"alternative-id":["S0376871612000737"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2012.02.021","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}